- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 411/00 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
Patent holdings for IPC class C07D 411/00
Total number of patents in this class: 61
10-year publication summary
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme LLC | 3751 |
3 |
| Bristol-myers Squibb Company | 4880 |
2 |
| Janssen Pharmaceutica N.V. | 3394 |
2 |
| Abbvie Inc. | 1800 |
2 |
| Hutchison MediPharma Enterprises Limited | 14 |
2 |
| Impact Biomedicines, Inc. | 31 |
2 |
| Spero Therapeutics, Inc. | 49 |
2 |
| Hoffmann-La Roche Inc. | 3439 |
1 |
| Genentech, Inc. | 3976 |
1 |
| Bayer Intellectual Property GmbH | 2498 |
1 |
| Amgen Inc. | 4076 |
1 |
| Merck Sharp & Dohme B.V. | 708 |
1 |
| FUJIFILM Corporation | 29437 |
1 |
| Sumitomo Chemical Company, Limited | 9043 |
1 |
| AbbVie Deutschland GmbH & Co. KG | 261 |
1 |
| Vertex Pharmaceuticals Incorporated | 1600 |
1 |
| Duke University | 3069 |
1 |
| Alexion Pharmaceuticals, Inc. | 638 |
1 |
| Arena Pharmaceuticals, Inc. | 365 |
1 |
| Astex Therapeutics Limited | 239 |
1 |
| Other owners | 33 |